SHARE CAPITAL | 6. SHARE CAPITAL Authorized The Company's authorized share capital consists of 500,000,000 common shares without par value. At December 31, 2019 and March 31, 2020, there were 187,573,671 shares issued and outstanding. Share issuances There were no share issuances during the three months ended March 31, 2020. Stock options The Company adopted an incentive stock option plan in 2006, as amended September 19, 2012 and reapproved by the Company’s shareholders on May 28, 2015 and May 30, 2018 (the “2006 Plan”). The essential elements of the 2006 Plan provide that the aggregate number of common shares of the Company that may be issued pursuant to options granted under the 2006 Plan and any other share-based compensation arrangements may not exceed 10% of the number of issued shares of the Company at the time of the granting of the options. Options granted under the 2006 Plan will have a maximum term of ten years. The exercise price of options granted under the 2006 Plan shall be fixed in compliance with the applicable provisions of the Toronto Stock Exchange (“TSX”) Company Manual in force at the time of grant and, in any event, shall not be less than the closing price of the Company’s common shares on the TSX on the trading day immediately preceding the day on which the option is granted, or such other price as may be agreed to by the Company and accepted by the TSX. Options granted under the 2006 Plan vest immediately, unless otherwise determined by the directors at the date of grant. A summary of the options granted under the 2006 Plan as of March 31, 2020 and December 31, 2019 is presented below: Three Months Ended Year Ended March 31, 2020 December 31, 2019 Weighted Weighted Average Aggregate Average Aggregate Number of Exercise Price Intrinsic Value Number of Exercise Price Intrinsic Value Options (C$) (C$) Options (C$) (C$) Balance, beginning of the period 2,452,049 $ 0.94 3,655,991 $ 0.98 Granted — — 187,232 0.85 Exercised — — (121,174) 0.70 Cancelled — — (1,270,000) 1.06 Balance, end of the period 2,452,049 $ 0.94 $ 9,100 2,452,049 $ 0.94 $ 59,734 The weighted average remaining life of options outstanding at March 31, 2020 was 3.1 years. Stock options outstanding are as follows: March 31, 2020 December 31, 2019 Exercise Number of Exercise Number of Expiry Date Price (C$) Options Exercisable Price (C$) Options Exercisable February 25, 2022 $ 1.11 510,000 510,000 $ 1.11 510,000 510,000 February 25, 2022 $ 0.73 270,000 270,000 $ 0.73 270,000 270,000 March 10, 2022 $ 1.11 120,000 120,000 $ 1.11 120,000 120,000 March 16, 2023 $ 1.00 580,000 580,000 $ 1.00 580,000 580,000 March 16, 2023 $ 0.50 130,000 130,000 $ 0.50 130,000 130,000 June 9, 2023 $ 1.00 30,000 30,000 $ 1.00 30,000 30,000 March 21, 2024 $ 0.61 374,817 374,817 $ 0.61 374,817 374,817 February 1, 2025 $ 250,000 250,000 $ 1.35 250,000 250,000 August 8, 2025 $ 0.85 187,232 187,232 $ 0.85 187,232 187,232 2,452,049 2,452,049 2,452,049 2,452,049 A summary of the non-vested options as of March 31, 2020 and changes during the three months ended March 31, 2020 is as follows: Weighted average grant- Number of date fair value Non-vested options: options (C$) Outstanding at December 31, 2019 — — Vested — — Outstanding at March 31, 2020 — — At March 31, 2020, there was no unrecognized compensation expense related to non-vested options outstanding. Deferred Share Unit Incentive Plan On April 4, 2017, the Company adopted a Deferred Share Unit Plan (the “DSU Plan”). On May 24, 2017, at the Company’s Annual General Meeting of Shareholders, the DSU Plan was approved. The maximum aggregate number of common shares that may be issued under the DSU Plan and the 2006 Plan is 10% of the number of issued and outstanding common shares (on a non-diluted basis). During the year ended December 31, 2019, the Company granted each of the members of the Board (other than those directors nominated for election by Paulson & Co., Inc.) 97,647 deferred share units (“DSUs”) with a grant date fair value (defined as the weighted average of the prices at which the common shares traded on the exchange with the most volume for the five days immediately preceding the grant) of C$0.85 per DSU representing C$83,000 per director or C$415,000 in the aggregate. The DSUs entitle the holders to receive common shares of the Company without the payment of any consideration. The DSUs vested immediately upon being granted but the common shares underlying the DSUs are not deliverable to the grantee until the grantee is no longer serving on the Board. DSUs outstanding are as follows: Three Months Ended Year Ended March 31, 2020 December 31, 2019 Weighted Average Weighted Number of Exercise Price Number of Average Exercise Units (C$) Units Price (C$) Balance, beginning of the period 1,383,396 $ 0.77 1,356,975 $ 0.72 Issued — — 488,235 $ 0.85 Delivered — — (461,814) $ 0.71 Balance, end of the period 1,383,396 $ 0.77 1,383,396 $ 0.77 Share-based payments During the three-month period ended March 31, 2020, there were no stock options granted under the 2006 Plan and no DSUs granted for common shares of the Company under the DSU Plan. Share-based payment compensation for the three months ended March 31, 2020 totaled $Nil. During the three-month period ended March 31, 2019, there were no stock options granted under the 2006 Plan and no DSUs granted for common shares of the Company under the DSU Plan. Share-based payment compensation for the three months ended March 31, 2019 totaled $1,686, which was included in wages and benefits in the statement of operations and comprehensive loss. |